LONDON (Reuters) – Banks, investors and big drug companies should consider creating a 10-billion-pound ($15.7 billion) “megafund” to help biotech firms in London and across Britain compete with U.S. rivals, …read more
Source:: UKScienceNews
LONDON (Reuters) – Banks, investors and big drug companies should consider creating a 10-billion-pound ($15.7 billion) “megafund” to help biotech firms in London and across Britain compete with U.S. rivals, …read more
Source:: UKScienceNews